“Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Events in Type 2 Diabetes”, IJBR, vol. 3, no. 1, pp. 320–324, Jan. 2025, doi: 10.70749/ijbr.v3i1.496.